COMP <GO>
MEDP vs ICLR // EV/EBITDA & P/E VALUATION
Medpace Holdings Inc. (NASDAQ) VS. ICON plc (NASDAQ) • 15-METRIC TALLY: MEDP 7
— ICLR 4
▲ EV/EBITDA & P/E VALUATION LEADER: ICLR
LAST: $652.01 (-3.77%) • MKT CAP: $18.95B
valuation
34.0x
LAST: $211.36 (-1.91%) • MKT CAP: $16.50B
valuation
31.7x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MEDP VS. ICLR)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MEDP | ICLR | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 27.90% | 3.10% | +24.80 | MEDP | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 34.0x | 31.7x | +2.30 | ICLR | /valuation <GO> |
| Free Cash Flow Yield | 3.60% | 5.22% | -1.62 | ICLR | /fcf-yield <GO> |
| Operating Margin | 21.10% | 5.40% | +15.70 | MEDP | /operating-margins <GO> |
| Net Profit Margin | 17.80% | 2.80% | +15.00 | MEDP | /net-margins <GO> |
| Revenue Growth (YoY) | 20.00% | 0.80% | +19.20 | MEDP | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 9.13 | 2.20 | +6.93 | MEDP | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 61.2 | 75.7 | -14.50 | ICLR | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.00 | 1.08 | -0.08 | ICLR | /macro-sensitivity <GO> |
| Forward P/E Multiple | 35.3x | 66.9x | -31.60 | MEDP | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $18.95B | $16.50B | $2.45B | MEDP | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MEDP REV | ICLR REV | MEDP GROSS % | ICLR GROSS % | MEDP FCF | ICLR FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.53B | $8.25B | — | — | $681.9M | $862.0M |
| FY 2024 | $2.11B | $8.19B | — | 28.6% | $572.3M | $1.12B |
| FY 2023 | $1.89B | $8.05B | — | — | $348.5M | $798.6M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MEDP // BETA 1.00
ICLR // BETA 1.08